UIIP NASB - Research and development
Search form
Authorization
Login:
Password:
Register
Forgot your password?
Partners

Automated decision support system for differential immune marker diagnostics of leukaemia and lymphomas («Dif-L» DSS))

Automated decision support system for differential immune marker diagnostics of leukaemia and lymphomas («Dif-L» DSS))

 

Principal researchers:  N. Novosiolova;O,Krasko

Key words:  Dif-L, DSS, leukaemia, lymphoma;

Field of application: public healthcare, the State Scientific and Practical Centre of Pediatric Oncology, hematology and immunology, medical universities, the Belarusian Medical Academy of Post-Graduate Education, regional clinics, immunologic laboratories, medical institutions of the Ministry of Healthcare of the Republic of Belarus.

Brief description, main features: full-fledged and prompt analysis of immunophenotyping results, aimed at differential diagnostics of leukaemia and lymphomas, providing the validity of medical decisions.

Novelty:  The product has no analogues in CIS countries. Basic types of leukaemia diagnostics accuracy is 99,2%. Subtypes of leukaemia diagnostics accuracy is to 88%. Standard analysis period is up to 1 minute. Heuristic analysis period is up to 10 minutes;

Degree of product availability: The system has been implemented into 8 medical and educational institutes of Ministry of Healthcare of the Republic of Belarus.

Cooperation: The contract for the provision of the right to use the “Dif-L” DSS  could be signed under the legal Decree issued in February 13, 2013

The main advantages of product implementing: medical diagnostic efficiency growth, increasing the efficiency of medical staff labor, speeding-up the  differential diagnostics.

Approximate cost:  -

Contacts:  academic secretary – Oleg V. Gorokh, tel.: 8 (017) 284-21-76; principal researcher – Natalia A. Novosiolova, tel.: 8 (017) 284-02-40.